13A-1090603
Know-how
Genetic compensation by compensatory gene expression ensures the functional robustness and maintains homeostasis against environmental challenges. The lack of understanding in the occurrence of cell-specific compensation in multicellular organisms and its implications for cancer robustness hinders current progress in cancer therapeutic strategies. Here, we propose that cell-specific gene compensation (quantified by a compensatory score, C-score) can serve as a buffering mechanism to fine-tune cell-specific functions. Applying C-score to cancer patients, we show expression of compensatory genes correlates with cancer patient features, and is predictive of cancer-specific synthetic lethality and cancer prognoses. We developed an analysis framework based on a simple cell-specific gene compensation mechanism that can be used to predict cancer-specific synthetic lethality, drug resistance and cancer patient survival.
- Design of cancer drug combinatorial therapy
- Method for predicting synthetic lethality
- A compensatory gene panel that can be used to predict cancer prognosis
- Synthetic lethality prediction may be used as selection criteria for potential biomarker
- Compensatory gene panel may be used as a diagnostic for cancer therapy management
- Method for making immune cells more robustness for immunotherapy
- Design of cancer drug combinatorial therapy
- Method for predicting synthetic lethality
- A compensatory gene panel that can be used to predict cancer prognosis
- Synthetic lethality prediction may be used as selection criteria for potential biomarker
- Compensatory gene panel may be used as a diagnostic for cancer therapy management
- Method for making immune cells more robustness for immunotherapy
Sheng-hong Chen
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Mechanism and Modeling of Human Disease-Associated Near-Exon Intronic Variants that Perturb RNA Splicing